DDRi R&D in CNS Tumors: Landscape & Opportunities
Time: 3:30 pm
day: Day Two
Details:
- Understanding the strong rationale for DDRi’s in CNS Tumors
- Optimizing systematic and efficient experimental drug qualification as a key opportunity to make profound impact on devastating diseases with a strong commercial case
